BioSpace News Archive

Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered into a research agreement with Genmab A/S of Denmark to create and develop bispecific antibodies using Genmab’s DuoBody® technology platform against disease relevant target antigens.

Regeneron Pharmaceuticals, Inc. announced the commencement of an underwritten public secondary offering of its common stock through which Sanofi intends to exit its investment in Regeneron shares.

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology.

Immunovia invites you to a teleconference for all stakeholders and media on Wednesday, May 27, 2020 at 16:30 CET.

Innovent Biologics, Inc. announced that the first patient has been successfully dosed in a Phase 1 clinical trial of anti-T-cell immunoreceptor with Ig and ITIM domains recombinant fully human monoclonal antibody drug candidate in China.

Transparency Market Research has published a new report titled, “Surgical Drainage Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

According to a new report published by Transparency Market Research, the vendor landscape of the global patient warming devices is extremely competitive.

Transparency Market Research has published a new report titled, “Lithotripsy Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Combi-chem and throughput screenings allow creation of several new materials in shortest possible time by using automation to their advantage.

DENTSPLY SIRONA Inc., the Dental Solutions Company, announced that it will participate in the Stifel 2020 Jaws and Paws Conference on May 27th.